CRMT

America's Car-Mart, Inc.

There isn't enough reported data to score CRMT yet.

F

Ford Motor Company

52
Fundamentals40/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential23/ 100

F lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

CRMT Fundamentals

MetricStatus
Weak
Weak
Healthy
Strong

CRMT's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.

F Fundamentals

MetricStatus
Stable
Under pressure
Under pressure
Strong

F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.

CRMT PE Valuation

CRMT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.1x next year's earnings.

F PE Valuation

F has no meaningful PE right now: it lost money over the past year.

CRMT Forward outlook

MetricOutlook
--
Returning to profit
Decline
Strongly improving
Limited
High

Analysts expect CRMT to return to profit, with revenue declining.

F Forward outlook

MetricOutlook
--
Strong growth
Stable
Improving
Limited
Low

F has the edge over CRMT on the outlook, with more favorable revenue expectations.

CRMT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.93 on Nov 12.

There is not enough scenario data to compare CRMT and F's risk to reward.

F Risk to reward

ScenarioChangePrice
Upside+31%$15.58
Downside-23%$9.16

Calculated from the latest close: $11.90 on Nov 12.

There is not enough scenario data to compare CRMT and F's risk to reward.

CRMT Earnings Per Share

Q4 2023: $-3.11Q1 2024: $-4.68Q2 2024: $-4.92Q3 2024: $-5.70Q4 2024: $-0.79Q1 2025: $0.92Q2 2025: $2.33Q3 2025: $1.79Q4 2025: $-1.53Q1 2026: $-11.15Q2 2026: $-16.79Q3 2026: $-24.38Forward: $0.82
Q4 2023: $-3.11Q1 2024: $-4.68Q2 2024: $-4.92Q3 2024: $-5.70Q4 2024: $-0.79Q1 2025: $0.92Q2 2025: $2.33Q3 2025: $1.79Q4 2025: $-1.53Q1 2026: $-11.15Q2 2026: $-16.79Q3 2026: $-24.38Forward: $0.82
QuarterTTM EPSYoY
Forward$0.82—
Q3 2026-$24.38-1462%
Q2 2026-$16.79-821%
Q1 2026-$11.15-1312%
Q4 2025-$1.53-$0.74
Q3 2025$1.79+$7.49
Q2 2025$2.33+$7.25
Q1 2025$0.92+$5.60
Q4 2024-$0.79+$2.32

CRMT has the edge over F on earnings, with more consistent year-over-year improvement.

F Earnings Per Share

Q4 2023: $1.08Q1 2024: $0.97Q2 2024: $0.96Q3 2024: $0.88Q4 2024: $1.46Q1 2025: $1.25Q2 2025: $0.78Q3 2025: $1.16Q4 2025: $-2.06Q1 2026: $-1.55Q2 2026: $-1.87Q3 2026: $-1.97Forward: $1.78
Q4 2023: $1.08Q1 2024: $0.97Q2 2024: $0.96Q3 2024: $0.88Q4 2024: $1.46Q1 2025: $1.25Q2 2025: $0.78Q3 2025: $1.16Q4 2025: $-2.06Q1 2026: $-1.55Q2 2026: $-1.87Q3 2026: $-1.97Forward: $1.78
QuarterTTM EPSYoY
Forward$1.78—
Q3 2026-$1.97-270%
Q2 2026-$1.87-340%
Q1 2026-$1.55-224%
Q4 2025-$2.06-241%
Q3 2025$1.16+32%
Q2 2025$0.78-19%
Q1 2025$1.25+29%
Q4 2024$1.46+35%

F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.

CRMT Quarterly Revenue

Q4 2023: $362MQ1 2024: $300MQ2 2024: $365MQ3 2024: $348MQ4 2024: $347MQ1 2025: $326MQ2 2025: $370MQ3 2025: $341MQ4 2025: $350MQ1 2026: $287MQ2 2026: $303MQ3 2026: $146M
Q4 2023: $362MQ1 2024: $300MQ2 2024: $365MQ3 2024: $348MQ4 2024: $347MQ1 2025: $326MQ2 2025: $370MQ3 2025: $341MQ4 2025: $350MQ1 2026: $287MQ2 2026: $303MQ3 2026: $146M
QuarterRevenueYoY
Q3 2026$145.8M-57%
Q2 2026$302.8M-18%
Q1 2026$286.8M-12%
Q4 2025$350.2M+0.8%
Q3 2025$341.3M-1.9%
Q2 2025$370.2M+1.5%
Q1 2025$325.7M+8.7%
Q4 2024$347.3M-4%

CRMT's revenue has slid since its 2023 peak: $146M last quarter, down 57% from the same quarter a year ago.

F Quarterly Revenue

Q4 2023: $46BQ1 2024: $42.8BQ2 2024: $47.8BQ3 2024: $46.2BQ4 2024: $48.2BQ1 2025: $40.7BQ2 2025: $50.2BQ3 2025: $50.5BQ4 2025: $45.9BQ1 2026: $43.3BQ2 2026: $48.3BQ3 2026: $49.5B
Q4 2023: $46BQ1 2024: $42.8BQ2 2024: $47.8BQ3 2024: $46.2BQ4 2024: $48.2BQ1 2025: $40.7BQ2 2025: $50.2BQ3 2025: $50.5BQ4 2025: $45.9BQ1 2026: $43.3BQ2 2026: $48.3BQ3 2026: $49.5B
QuarterRevenueYoY
Q3 2026$49.5B-2%
Q2 2026$48.3B-3.8%
Q1 2026$43.3B+6.4%
Q4 2025$45.9B-4.8%
Q3 2025$50.5B+9.4%
Q2 2025$50.2B+5%
Q1 2025$40.7B-5%
Q4 2024$48.2B+4.9%

F has the edge over CRMT on sales, with more consistent year-over-year improvement.

CRMT Free Cash Flow

Q4 2023: −$32MQ1 2024: $10MQ2 2024: −$12MQ3 2024: −$16MQ4 2024: −$24MQ1 2025: −$32MQ2 2025: $18MQ3 2025: −$6MQ4 2025: $8MQ1 2026: −$6MQ2 2026: $67MQ3 2026: $80M
Q4 2023: −$32MQ1 2024: $10MQ2 2024: −$12MQ3 2024: −$16MQ4 2024: −$24MQ1 2025: −$32MQ2 2025: $18MQ3 2025: −$6MQ4 2025: $8MQ1 2026: −$6MQ2 2026: $67MQ3 2026: $80M
QuarterFree cash flowYoY
Q3 2026$80M+$86.4M
Q2 2026$67.4M+266%
Q1 2026-$6.2M+$25.3M
Q4 2025$8.3M+$31.9M
Q3 2025-$6.4M+$9.6M
Q2 2025$18.4M+$30.4M
Q1 2025-$31.5M-408%
Q4 2024-$23.6M+$7.9M

CRMT has the edge over F on cash flow, with more consistent year-over-year improvement.

F Free Cash Flow

Q4 2023: $197MQ1 2024: −$709MQ2 2024: $3.4BQ3 2024: $3.5BQ4 2024: $530MQ1 2025: $1.9BQ2 2025: $4.2BQ3 2025: $5.3BQ4 2025: $1.1BQ1 2026: −$1.1BQ2 2026: $2BQ3 2026: $3.1B
Q4 2023: $197MQ1 2024: −$709MQ2 2024: $3.4BQ3 2024: $3.5BQ4 2024: $530MQ1 2025: $1.9BQ2 2025: $4.2BQ3 2025: $5.3BQ4 2025: $1.1BQ1 2026: −$1.1BQ2 2026: $2BQ3 2026: $3.1B
QuarterFree cash flowYoY
Q3 2026$3.1B-40%
Q2 2026$2B-54%
Q1 2026-$1.1B-157%
Q4 2025$1.1B+108%
Q3 2025$5.3B+50%
Q2 2025$4.2B+24%
Q1 2025$1.9B+$2.6B
Q4 2024$530M+169%

F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.

CRMT Total Shares

Q4 2023: 6MQ1 2024: 6MQ2 2024: 6MQ3 2024: 6MQ4 2024: 8MQ1 2025: 8MQ2 2025: 8MQ3 2025: 8MQ4 2025: 8MQ1 2026: 8MQ2 2026: 8MQ3 2026: 8M
Q4 2023: 6MQ1 2024: 6MQ2 2024: 6MQ3 2024: 6MQ4 2024: 8MQ1 2025: 8MQ2 2025: 8MQ3 2025: 8MQ4 2025: 8MQ1 2026: 8MQ2 2026: 8MQ3 2026: 8M
PeriodChange %Net change
Quarterly+0.5%+40.2K shares
1 year+0.7%+55.5K shares
3 years+26%+1.7M shares
5 years+19%+1.3M shares
Available history+20%+1.4M shares

CRMT has 8M diluted shares, up 0.7% from a year ago, despite $255,000 in buybacks over the past year.

F Total Shares

Q4 2023: 4BQ1 2024: 4BQ2 2024: 4BQ3 2024: 4BQ4 2024: 4BQ1 2025: 4BQ2 2025: 4BQ3 2025: 4BQ4 2025: 4BQ1 2026: 4.1BQ2 2026: 4BQ3 2026: 4.1B
Q4 2023: 4BQ1 2024: 4BQ2 2024: 4BQ3 2024: 4BQ4 2024: 4BQ1 2025: 4BQ2 2025: 4BQ3 2025: 4BQ4 2025: 4BQ1 2026: 4.1BQ2 2026: 4BQ3 2026: 4.1B
PeriodChange %Net change
Quarterly+2.2%+89M shares
1 year+0.7%+28M shares
3 years+0.6%+26M shares
5 years+1%+40M shares
Available history+1.8%+72M shares

F has 4.1B diluted shares, up 0.7% from a year ago.

CRMT Net Leverage

Q4 2024: -2.3xQ1 2025: -0.5xQ2 2025: -0.3xQ3 2025: -0.4x
Q4 2024: -2.3xQ1 2025: -0.5xQ2 2025: -0.3xQ3 2025: -0.4x
QuarterNet LeverageStatus
Q3 2025-0.4xNet Cash
Q2 2025-0.3xNet Cash
Q1 2025-0.5xNet Cash
Q4 2024-2.3xNet Cash
Q3 2023-0.3xNet Cash
Q2 20235.1xHigh
Q4 20223.5xElevated
Q3 20221.7xHealthy

CRMT has more cash than debt.

F Net Leverage

Q4 2023: -1.9xQ1 2024: -1.6xQ2 2024: -1.7xQ3 2024: -2.1xQ4 2024: -1.8xQ1 2025: -1.8xQ2 2025: -2.2xQ3 2025: -2.4xQ4 2025: -3.4xQ1 2026: -2.0xQ2 2026: -2.1xQ3 2026: -2.5x
Q4 2023: -1.9xQ1 2024: -1.6xQ2 2024: -1.7xQ3 2024: -2.1xQ4 2024: -1.8xQ1 2025: -1.8xQ2 2025: -2.2xQ3 2025: -2.4xQ4 2025: -3.4xQ1 2026: -2.0xQ2 2026: -2.1xQ3 2026: -2.5x
QuarterNet LeverageStatus
Q3 2026-2.5xNet Cash
Q2 2026-2.1xNet Cash
Q1 2026-2.0xNet Cash
Q4 2025-3.4xNet Cash
Q3 2025-2.4xNet Cash
Q2 2025-2.2xNet Cash
Q1 2025-1.8xNet Cash
Q4 2024-1.8xNet Cash

F has more cash than debt.

CRMT Weekly Momentum

MetricValueStatus
RSI28.1Oversold
Stochastic18.7Oversold

CRMT's weekly RSI is 28 (oversold) and its Stochastic is 19 (oversold).

F Weekly Momentum

MetricValueStatus
RSI41.5Neutral
Stochastic19.6Oversold

F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).

CRMT PE vs Consumer Cyclical Sector

MetricCRMTSector medianRelative
PEN/A18x—

CRMT has no meaningful PE right now: it lost money over the past year.

F PE vs Consumer Cyclical Sector

MetricFSector medianRelative
PEN/A18x—

F has no meaningful PE right now: it lost money over the past year.

CRMT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.0915% below
20 week MA$2.0956% below
50 week MA$11.092% below
100 week MA$27.097% below
200 week MA$49.698% below

CRMT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.

F Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.22.5% below
20 week MA$13.311% below
50 week MA$13.411% below
100 week MA$12.12% below
200 week MA$12.11.4% below

F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.

CRMT Yearly ROI

YearStart priceEnd priceROI
2020$108.6$110.0+1.3%
2021$110.0$102.8-6.5%
2022$102.8$72.1-30%
2023$72.1$75.8+5.1%
2024$75.8$52.3-31%
2025$52.3$25.9-51%
2026 YTD$25.9$0.93-96%

CRMT has finished lower in four of the last six years. It's down 96% so far in 2026.

F Yearly ROI

YearStart priceEnd priceROI
2020$9.36$8.86-5.3%
2021$8.86$20.3+129%
2022$20.3$11.4-44%
2023$11.4$12.2+7.3%
2024$12.2$10.0-18%
2025$10.0$13.3+33%
2026 YTD$13.3$11.9-11%

F has the edge over CRMT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key